Rheumatoid arthritis aggravated and Abnormal clotting factor

Summary:

Abnormal clotting factor is found among people with Rheumatoid arthritis aggravated, especially for people who are female, 60+ old.

The study analyzes which people have Abnormal clotting factor with Rheumatoid arthritis aggravated. It is created by eHealthMe based on reports of 14 people who have Rheumatoid arthritis aggravated from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Rheumatoid arthritis aggravated?

Rheumatoid arthritis aggravated (chronic progressive disease causing inflammation in the joints) is found to be associated with 1,373 drugs and 375 conditions by eHealthMe. Check the latest studies of Rheumatoid arthritis aggravated.

What is Abnormal clotting factor?

Abnormal clotting factor is found to be associated with 36 drugs and 184 conditions by eHealthMe. Check the latest studies of Abnormal clotting factor.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

14 people who have Rheumatoid Arthritis Aggravated and Abnormal Clotting Factor are studied.

Would you have Abnormal clotting factor when you have Rheumatoid arthritis aggravated?

Gender of people who have Rheumatoid Arthritis Aggravated and experienced Abnormal Clotting Factor *:

female: 64.29 %
male: 35.71 %

Age of people who have Rheumatoid Arthritis Aggravated and experienced Abnormal Clotting Factor *:

Common co-existing conditions for these people *:

Stress And Anxiety: 4 people, 28.57%
Swelling: 3 people, 21.43%
High Blood Cholesterol: 3 people, 21.43%
Sleep Disorder: 3 people, 21.43%
Ankylosing Spondylitis (type of arthritis affecting the spine): 3 people, 21.43%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 3 people, 21.43%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 3 people, 21.43%
Pulmonary Thrombosis (scarring in the lungs): 2 people, 14.29%
Depression: 1 person, 7.14%
Enlarged Prostate: 1 person, 7.14%

Common drugs taken by these people *:

Common symptoms for these people *:

Weakness: 4 people, 28.57%
Fall: 4 people, 28.57%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 3 people, 21.43%
Haematemesis (vomiting of blood): 3 people, 21.43%
Pulmonary Thrombosis (scarring in the lungs): 3 people, 21.43%
Urinary Retention (the inability to completely or partially empty the bladder): 3 people, 21.43%
Malaise (a feeling of general discomfort or uneasiness): 3 people, 21.43%
Thrombosis (formation of a blood clot inside a blood vessel): 3 people, 21.43%
Sensory Disturbance (sense disturbance): 3 people, 21.43%
Arthropathy: 3 people, 21.43%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Abnormal clotting factor?

- Check whether Abnormal clotting factor is associated with a drug or a condition

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Abnormal clotting factor and Rheumatoid arthritis aggravated, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.